The forecast for liver malignant neoplasms mortality among men in the United States indicates a steady increase in mortality rates from 12.8 male deaths per 100,000 in 2024 to 13.7 in 2028. The year-on-year analysis shows a consistent rise at approximately 1.5% annually over these years. Compared to the baseline from 2023, the cumulative addition in 2024 is expected to show an upward trend.
Future trends to watch include potential impacts of advancements in medical treatments, changes in risk factor prevalence like alcohol consumption and obesity, and innovations in early detection and screening for liver malignancies, which may influence future mortality rates.
